Article
5-Alkyl-2-alkylamino-6-(2,6-difluorophenylalkyl)-3,4-dihydropyrimidin-4(3H)-ones, a new series of potent, broad-spectrum non-nucleoside reverse transcriptase inhibitors belonging to the DABO family.
Bioorganic & medicinal chemistry - 15 Mar 2005
Mai Antonello, Artico Marino, Ragno Rino, Sbardella Gianluca, Massa Silvio, Musiu Chiara, Mura Massimo, Marturana Flavia, Cadeddu Alessandra, Maga Giovanni, La Colla Paolo
Abstract excerpt
2-Alkylamino-6-[1-(2,6-difluorophenyl)alkyl]-3,4-dihydro-5-alkylpyrimidin-4(3H)-ones (F(2)-NH-DABOs) 4, 5 belonging to the dihydro-alkoxy-benzyl-oxopyrimidine (DABO) family and bearing different alkyl- and arylamino side chains at the C(2)-position of the pyrimidine ring were designed as active against wild type (wt) human immunodeficiency virus type 1 (HIV-1) and some relevant HIV-1 mutants. Biological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.